Lead sponsor
Anavex Life Sciences Corp.
4 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of July 21, 2026.
4
Trials led
0
Ongoing
485
Total enrollment
60
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 2
3
Phase 2/3
1
Trials by status
Completed
4
Trials led
TrialEligibility highlightPhaseStatusEnrollment
OLE Study for Patients With Parkinson's Disease With Dementia Enrolled in Study ANAVEX2-73-PDD-001Parkinson's disease dementiaPh 2Completed132
An Extension Study of ANAVEX2-73 in Patients With Mild to Moderate Alzheimer's Diseasemild-to-moderate ADPh 2Completed21